Evaluation of dendritic cells in peripheral blood and pleural effusion of non-small-cell lung cancer patients

A. Surdacka, S. Chocholska, I. Jastrzebska, J. Milanowski, J. Rolinski (Lublin, Poland)

Source: Annual Congress 2004 - Mesothelioma and malignant pleural effusions - pollution and cancer
Session: Mesothelioma and malignant pleural effusions - pollution and cancer
Session type: Thematic Poster Session
Number: 3288
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Surdacka, S. Chocholska, I. Jastrzebska, J. Milanowski, J. Rolinski (Lublin, Poland). Evaluation of dendritic cells in peripheral blood and pleural effusion of non-small-cell lung cancer patients. Eur Respir J 2004; 24: Suppl. 48, 3288

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 772s
Year: 2006

Oncodrivers in malignant pleural effusions associated with non-small cell lung cancer
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020


Cytotoxic T-lymphocyte status in peripheral blood and malignant pleural effusion in lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 63s
Year: 2003

Evaluation of concomitant pleural effusions in patients with lung cancers
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007

Sensitivity of PD-L1 analysis from pleural effusion in non-small cell lung cancer
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020


High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer
Source: ERJ Open Res, 7 (1) 00787-2020; 10.1183/23120541.00787-2020
Year: 2021



Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006

A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018



Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

Hypotonic carboplatin pleurodesis for malignant pleural effusion of non-small cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 273s
Year: 2002

Pleural effusion in lung cancer and targeted therapy
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Pleural effusions in lung cancer
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012

A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Survival of lung adenocarcinoma patients with malignant pleural effusion
Source: Eur Respir J 2013; 41: 1409-1418
Year: 2013



Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Surgery for lung cancer with pleural effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 180s
Year: 2002

Malignant pericardial effusion in lung cancer patients
Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Year: 2006